Department of Neurology and Clinical Neurophysiology, St. Elisabeth Hospital, Tilburg, The Netherlands.
Clin Neurophysiol. 2012 Apr;123(4):838-41. doi: 10.1016/j.clinph.2011.08.022. Epub 2011 Oct 1.
Carpal tunnel syndrome (CTS) is a common entrapment neuropathy. A local corticosteroid injection at the carpal tunnel inlet is often given to reduce the signs and symptoms. The long term effect of a local corticosteroid injection is not known yet. The aims of the study were to assess the long term effect of a local corticosteroid injection and the rognostic factors.
Assessment of 419 consecutive patients, seen between November 2004 and November 2007 at our Neurology out-patient clinic. After confirmation of the diagnosis CTS the treating neurologist decided on the patients eligibility for a local corticosteroid injection, containing 40 mg methylprednisolone.
Local corticosteroid injection was given to 273 of the 419 patients with CTS (65%), 122 (29%) were treated surgically and 24 (6%) were treated by another therapy. Of the 273 patients long term follow-up was available for 211 (77%) patients. A beneficial effect of more than 6 months was seen in 132 patients (63%), longer than 12 months in 102 patients (48%), and longer than 18 months in 71 patients (34%). Only severity of electrodiagnostic testing was a predictor of outcome. The median time until treatment failure was 15 months for mild, 5 months for moderate and 4.5 months for severe CTS (logrank test p=0.02).
Patients with an electrodiagnostically mild CTS (i.e., abnormal comparative tests or prolonged median DSL>3.5 ms but normal median DML) are good candidates for a local steroid injection with 50% having a good long term effect for more than 15 months.
This study shows that the EMG severity of CTS is an important prognostic factor for the long term effect of a local steroid injection.
腕管综合征(CTS)是一种常见的嵌压性神经病。在腕管入口处局部注射皮质类固醇通常用于减轻症状。局部皮质类固醇注射的长期效果尚不清楚。本研究的目的是评估局部皮质类固醇注射的长期效果和预后因素。
评估了 2004 年 11 月至 2007 年 11 月在我院神经内科门诊就诊的 419 例连续患者。在确诊 CTS 后,治疗神经病学家根据患者接受局部皮质类固醇注射的资格决定,该注射含有 40mg 甲基强的松龙。
419 例 CTS 患者中,273 例(65%)接受了局部皮质类固醇注射,122 例(29%)接受了手术治疗,24 例(6%)接受了其他治疗。273 例患者中,211 例(77%)有长期随访。132 例(63%)患者疗效超过 6 个月,102 例(48%)患者疗效超过 12 个月,71 例(34%)患者疗效超过 18 个月。只有电诊断测试的严重程度是预后的预测因素。轻度 CTS 的治疗失败时间中位数为 15 个月,中度为 5 个月,重度为 4.5 个月(对数秩检验,p=0.02)。
电诊断轻度 CTS(即异常比较测试或延长的中位 DSL>3.5ms 但正常的中位 DML)患者是局部类固醇注射的良好候选者,50%的患者有良好的长期效果,超过 15 个月。
本研究表明,肌电图 CTS 的严重程度是局部类固醇注射长期效果的重要预后因素。